A Dose-escalation Study to Investigate Safety and Toleration of OZ439
NCT01713608
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Interventions
DRUG:
OZ439
Sponsor
Medicines for Malaria Venture